The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: Protocol for an updated systematic review and meta-analysis

The antipsychotic aripiprazole induces peripheral antinociceptive effects through PI3Kγ/NO/cGMP/K ATP pathway activation

(2022) Renata C. M. Ferreira et al.   EUROPEAN JOURNAL OF PAIN

Healthcare costs and resource use associated with negative symptoms of schizophrenia: A systematic literature review

(2022) Sharon Weber et al.   SCHIZOPHRENIA RESEARCH

Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia

(2022) Ammara Saleem et al.   Frontiers in Pharmacology

Management of Hypertensive Crises in Children: A Review of the Recent Literature

(2022) Nicola Bertazza Partigiani et al.   Frontiers in Pediatrics

Abnormal synaptic plasticity and impaired cognition in schizophrenia

(2022) Xiu-Lin Wu et al.   World Journal of Psychiatry

Targeting NMDA receptors in neuropsychiatric disorders by drug screening on human neurons derived from pluripotent stem cells

(2022) Wenbo Zhang et al.   Translational Psychiatry

Treatment-resistant schizophrenia – A RCT on the effectiveness of repeated-dose sodium nitroprusside

(2021) Marcelo P.M. Adelino et al.   SCHIZOPHRENIA RESEARCH

The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows

(2021) Elli Zoupa et al.   MOLECULES

Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study

(2020) Kate Merritt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Brain NMDA Receptors in Schizophrenia and Depression

(2020) Albert Adell   Biomolecules

Hypertension is associated with blunted NO-mediated leg vasodilator responsiveness that is reversed by high-intensity training in postmenopausal women

(2020) Thomas P. Gunnarsson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia

(2019) Hannah E. Brown et al.   JAMA Psychiatry

Exact inference for the random‐effect model for meta‐analyses with rare events

(2019) Jessica Gronsbell et al.   STATISTICS IN MEDICINE

Household economic burden and outcomes of patients with schizophrenia after being unlocked and treated in rural China

(2019) L. Xu et al.   Epidemiology and Psychiatric Sciences

Current Concepts and Treatments of Schizophrenia

(2018) Piotr Stępnicki et al.   MOLECULES

Restoration of metabolic health by decreased consumption of branched-chain amino acids

(2017) Nicole E. Cummings et al.   JOURNAL OF PHYSIOLOGY-LONDON

A novel random effect model for GWAS meta-analysis and its application to trans-ethnic meta-analysis

(2016) Jingchunzi Shi et al.   BIOMETRICS

Schizophrenia

(2016) Michael J Owen et al.   LANCET

Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia

(2015) Ludmyla Kandratavicius et al.   BMC NEUROSCIENCE

The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats

(2015) Aikaterini Trevlopoulou et al.   PSYCHOPHARMACOLOGY

Risks of all-cause and suicide mortality in mental disorders: a meta-review

(2014) Edward Chesney et al.   World Psychiatry

Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside

(2013) Jaime E. C. Hallak et al.   JAMA Psychiatry

The mental health workforce gap in low- and middle-income countries: a needs-based approach

(2011) Tim A Bruckner et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The Continuum of Psychotic Symptoms in the General Population: A Cross-national Study

(2010) R. Nuevo et al.   SCHIZOPHRENIA BULLETIN